Evidence map›Paper›PMID 38585440›Full record

ArticleNeurology. Clinical practice2024

The Cost of After-Hour Electroencephalography.

John P Ney, Marc R Nuwer, Lawrence J Hirsch, Mark Burdelle, Kellee Trice, Josef Parvizi

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John P NeySchool of Medicine (JPN), Boston University, MA; Departments of Neurology (MRN), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (LJH), Yale University School of Medicine, New Haven, CT; Department of Neurology and Neurological Sciences (MB, JP), Stanford University School of Medicine, CA; and Neurodiagnostic Technology Programs (KT), Institute of Health Sciences, Hunt Valley, MD.ORCID https://orcid.org/0000-0003-3479-6441
Marc R NuwerSchool of Medicine (JPN), Boston University, MA; Departments of Neurology (MRN), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (LJH), Yale University School of Medicine, New Haven, CT; Department of Neurology and Neurological Sciences (MB, JP), Stanford University School of Medicine, CA; and Neurodiagnostic Technology Programs (KT), Institute of Health Sciences, Hunt Valley, MD.ORCID https://orcid.org/0000-0001-6916-153X
Lawrence J HirschSchool of Medicine (JPN), Boston University, MA; Departments of Neurology (MRN), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (LJH), Yale University School of Medicine, New Haven, CT; Department of Neurology and Neurological Sciences (MB, JP), Stanford University School of Medicine, CA; and Neurodiagnostic Technology Programs (KT), Institute of Health Sciences, Hunt Valley, MD.ORCID https://orcid.org/0000-0002-6333-832X
Mark BurdelleSchool of Medicine (JPN), Boston University, MA; Departments of Neurology (MRN), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (LJH), Yale University School of Medicine, New Haven, CT; Department of Neurology and Neurological Sciences (MB, JP), Stanford University School of Medicine, CA; and Neurodiagnostic Technology Programs (KT), Institute of Health Sciences, Hunt Valley, MD.
Kellee TriceSchool of Medicine (JPN), Boston University, MA; Departments of Neurology (MRN), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (LJH), Yale University School of Medicine, New Haven, CT; Department of Neurology and Neurological Sciences (MB, JP), Stanford University School of Medicine, CA; and Neurodiagnostic Technology Programs (KT), Institute of Health Sciences, Hunt Valley, MD.ORCID https://orcid.org/0009-0007-4612-0058
Josef ParviziSchool of Medicine (JPN), Boston University, MA; Departments of Neurology (MRN), University of California Los Angeles David Geffen School of Medicine; Department of Neurology (LJH), Yale University School of Medicine, New Haven, CT; Department of Neurology and Neurological Sciences (MB, JP), Stanford University School of Medicine, CA; and Neurodiagnostic Technology Programs (KT), Institute of Health Sciences, Hunt Valley, MD.ORCID https://orcid.org/0000-0001-8520-7948

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Background and Objectives: High costs associated with after-hour electroencephalography (EEG) constitute a barrier for financially constrained hospitals to provide this neurodiagnostic procedure outside regular working hours. Our study aims to deepen our understanding of the cost elements involved in delivering EEG services during after-hours. Methods: We accessed publicly available data sets and created a cost model depending on 3 most commonly seen staffing scenarios: (1) technologist on-site, (2) technologist on-call from home, and (3) a hybrid of the two. Results: Cost of EEG depends on the volume of testing and the staffing plan. Within the various cost elements, labor cost of EEG technologists is the predominant expenditure, which varies across geographic regions and urban areas. Discussion: We provide a model to explain why access to EEGs during after-hours has a substantial expense. This model provides a cost calculator tool (made available as part of this publication in eAppendix 1, links.lww.com/CPJ/A513) to estimate the cost of EEG platform based on site-specific staffing scenarios and annual volume.

Identifiers

PMID38585440
PMCPMC10997216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.